Skip to search formSkip to main contentSkip to account menu

Inflammatory disease of mucous membrane

Known as: MUCOUS MEMBRANE INFLAMMATION, Mucositis NOS, Mucositis 
An INFLAMMATION of the MUCOSA with burning or tingling sensation. It is characterized by atrophy of the squamous EPITHELIUM, vascular damage… 
National Institutes of Health

Related topics

Related topics

16 relations
CatarrhGastrointestinal mucositisIn BloodMicrobiological

Broader (2)

Disease of mucous membraneGastrointestinal Diseases

Narrower (1)

Stomatitis

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
The Clinical Effect of the Dual-Targeting Strategy Involving PI3K/AKT/mTOR and RAS/MEK/ERK Pathways in Patients with Advanced Cancer
Purpose: This study evaluated the clinical relevance of the dual-targeting strategy involving PI3K/AKT/mTOR and RAF/MEK/ERK… 
Highly Cited
2007
Highly Cited
2007
Clinical Practice Guidelines for the Prevention and Treatment of Mucositis
Dorothy M. Keefe, MD Mark M. Schubert, DDS, MSD Linda S. Elting, DrPH Stephen T. Sonis, DMD, DMSc Joel B. Epstein, DMD, MSD… 
Highly Cited
2005
Highly Cited
2005
Mitogenic Influence of Human R-Spondin1 on the Intestinal Epithelium
Several described growth factors influence the proliferation and regeneration of the intestinal epithelium. Using a transgenic… 
Highly Cited
2005
Highly Cited
2005
Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer.
PURPOSE In this study, two doses of temsirolimus (CCI-779), a novel inhibitor of the mammalian target of rapamycin, were… 
Highly Cited
2000
Highly Cited
2000
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease
Abstract Background & Aims: Interleukin 10 (IL-10) is an anti-inflammatory, immunomodulatory cytokine that regulates mucosal… 
Highly Cited
1999
Highly Cited
1999
Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy
An impediment to mucositis research has been the lack of an accepted, validated scoring system. The objective of this study was… 
Highly Cited
1997
Highly Cited
1997
Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer.
Highly Cited
1995
Highly Cited
1995
A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis.
BACKGROUND Cystic fibrosis is a monogenic disease that deranges multiple systems of ion transport in the airways, culminating in… 
Review
1994
Review
1994
Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer.
Paclitaxel is a new anticancer agent with a novel mechanism of action. It promotes polymerisation of tubulin dimers to form… 
Review
1986
Review
1986
Mitoxantrone: a new anticancer drug with significant clinical activity.
Clinical studies using mitoxantrone, an anthraquinone, were begun in the United States in 1979. Subsequent phase II and III… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)